Received: 26 September 2018
Accepted: 8 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: This study was a retrospective audit of care provided to each patient group in our region as a comparison to guidelines and published data. Implied consent for clinical audit purposes in line with standard practice. Data presented is not intended to be transferable and therefore as per Health Research Authority, UK guidelines does not require ethical approval.
: Not applicable.
: GG, RM, JM, NR, MC – no competing interests to declare.MFM – Novartis: Honorarium, speaker fee. Celgene: Speaker fee. Bristol Myer Squibb: Honorarium.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.